Business Context and Reporting Period
Company: Inmune Bio, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: May 28, 2019
Reporting Period: Event-based (May 28, 2019)
Context: The filing serves as a Regulation FD disclosure to announce an upcoming investor presentation by the Company's Chief Financial Officer.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event disclosure and does not contain financial statements or performance metrics.
Material Changes
No material changes to financial position or operations are reported in this filing. The document solely announces a scheduled corporate event.
Guidance, Outlook, and Management Commentary
- Event Announcement: CFO David Moss will present at the 9th Annual LD Micro Invitational in Bel-Air, California.
- Event Dates: June 4-5, 2019.
- Management Availability: Company management will be available for one-on-one meetings during the event.
- Exhibit Reference: The press release regarding this event is included as Exhibit 99.1.
Investor Verification Checklist
- Verify the specific date and time of the CFO's presentation at the LD Micro Invitational.
- Review the content of the press release furnished as Exhibit 99.1 for additional details on the presentation topic.
- Confirm if the Company has issued any subsequent updates regarding the event or management availability.